ClinicalTrials.govpublic full text
Efficacy, Safety, Tolerability and Pharmacokinetics (PK) of Nilotinib (AMN107) in Pulmonary Arterial Hypertension (PAH)
pulmonary arterial hypertension, nilotinib, 6mwd, pulmonary hypertension, interventional, phase2
This document is indexed with metadata only — full text is not available in the archive for this record.
Open the official source ↗
Related documents
Record · ID 966987
Retrieved via
Conceptio — every document is proof-bundled with source, license, and retrieval metadata.